EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Impact of Extranodal Organ Burden in Classical Hodgkin Lymphoma with Extranodal Involvement: A Retrospective Cohort Analysis

Salih Sertaç Durusoy iD, Tayfur Toptaş iD, Derviş Murat Akkurd iD, Ali Tekbaş iD, Abdi İbrahim Halil Sönmez iD, Handan Haydaroğlu Şahin iD, Vahap Okan iD

Journal of Clinical Medicine · 04.08.2026 · 15 (15) · 6067

DOI: 10.3390/jcm15156067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 04.08.2026. Verfasst von Salih Sertaç Durusoy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Ali Osman Sönmez Oncology Hospital, Bursa 16040, Türkiye. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The prognostic significance of extranodal disease in classical Hodgkin lymphoma remains incompletely defined. Although contemporary models such as the Advanced Hodgkin International Prognostic Index (A-HIPI) improve systemic risk stratification, it remains unclear whether outcomes are more closely associated with specific extranodal organ involvement or with the overall burden of extranodal dissemination.

Methods

This retrospective single-center study included 89 patients with predominantly advanced-stage classical Hodgkin lymphoma, including a minority of high-risk stage II bulky cases, and documented extranodal involvement at diagnosis. Extranodal disease was evaluated according to both organ-specific involvement and extranodal organ burden (EOB), defined as single extranodal organ involvement (single EO) versus involvement of two or more extranodal organs (≥2 EO). Overall survival (OS) and progression-free survival (PFS) were assessed using Kaplan–Meier analysis and Cox proportional hazard models. Risk stratification was examined using both the International Prognostic Score (IPS) and A-HIPI.

Results

Patients with ≥2 EO had significantly inferior OS compared with those with single EO involvement (5-year OS, 66.8% vs. 96.7%; log-rank p = 0.018), whereas the difference in PFS did not reach statistical significance (5-year PFS, 49.6% vs. 73.5%; log-rank p = 0.108). A-HIPI-based stratification significantly discriminated OS (5-year OS, 92.2% vs. 78.2%; p = 0.001) and showed borderline discrimination for PFS (5-year PFS, 71.5% vs. 57.2%; p = 0.053). In the combined analysis, patients with high A-HIPI risk and ≥2 EO had the poorest outcomes, with a 5-year PFS of 34.1% and a 5-year OS of 25.0%. In a parsimonious multivariable Cox model including EOB and A-HIPI-predicted 5-year risk as a continuous variable, ≥2 EO remained associated with inferior OS (HR 3.83, 95% CI 1.34–10.97; p = 0.013), while its association with PFS was adverse but not statistically significant (HR 1.83, 95% CI 0.86–3.88; p = 0.114). Organ-specific extranodal involvement showed limited and inconsistent associations with survival across A-HIPI- and IPS-defined subgroups.

Conclusions

In this retrospective single-center cohort, involvement of multiple extranodal organs was associated with inferior OS after adjustment for continuous A-HIPI-predicted risk, whereas its association with PFS did not reach statistical significance. Individual extranodal sites showed no consistent prognostic associations. These exploratory and hypothesis-generating findings suggest that quantitative assessment of extranodal organ burden may complement existing clinical risk measures; however, confirmation in larger, contemporary, externally validated cohorts is required before clinical application.

Schlagwörter

Stichwörter der Autor:innen

A-HIPIclassical Hodgkin lymphomaextranodal diseaseextranodal organ burdenoverall survivalprognosis

Autor:innen und Institutionen

  • Department of Hematology, Ali Osman Sönmez Oncology Hospital, Bursa 16040, Türkiye.
  • Department of Hematology, Faculty of Medicine, Marmara University, İstanbul 34899, Türkiye.
  • Department of Hematology, Mersin City Training and Research Hospital, Mersin 33110, Türkiye.
  • Department of Hematology, Gaziantep City Hospital, Gaziantep 27010, Türkiye.
  • Department of Hematology, Kilis Prof. Dr. Alaeddin Yavaşça State Hospital, Kilis 79090, Türkiye.
  • Department of Hematology, Faculty of Medicine, Gaziantep University, Gaziantep 27310, Türkiye.

ORCID-Profile: Salih Sertaç Durusoy, Tayfur Toptaş, Derviş Murat Akkurd, Ali Tekbaş, Abdi İbrahim Halil Sönmez, Handan Haydaroğlu Şahin, Vahap Okan

Zitieren

APA

Durusoy, S. S., Toptaş, T., Akkurd, D. M., Tekbaş, A., Sönmez, A. İ. H., Şahin, H. H., & Okan, V. (2026). Prognostic Impact of Extranodal Organ Burden in Classical Hodgkin Lymphoma with Extranodal Involvement: A Retrospective Cohort Analysis. Journal of Clinical Medicine, 15(15), 6067. https://doi.org/10.3390/jcm15156067

Vancouver

Durusoy SS, Toptaş T, Akkurd DM, Tekbaş A, Sönmez AİH, Şahin HH, et al. Prognostic Impact of Extranodal Organ Burden in Classical Hodgkin Lymphoma with Extranodal Involvement: A Retrospective Cohort Analysis. Journal of Clinical Medicine. 2026;15(15):6067. doi:10.3390/jcm15156067

BibTeX
@article{Durusoy2026,
  author = {Durusoy, Salih Sertaç and Toptaş, Tayfur and Akkurd, Derviş Murat and Tekbaş, Ali and Sönmez, Abdi İbrahim Halil and Şahin, Handan Haydaroğlu and Okan, Vahap},
  title = {Prognostic Impact of Extranodal Organ Burden in Classical Hodgkin Lymphoma with Extranodal Involvement: A Retrospective Cohort Analysis},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {15},
  pages = {6067},
  doi = {10.3390/jcm15156067}
}
Kostenlos starten →